The UK medicine regulator said on Monday that it will make a decision on the Pfizer/Bio NTech Covid 19 vaccine in the " shortest time possible " now it has received further data . 
" It is our job now to rigorously assess these data and the evidence submitted on the vaccine ’s safety , quality and effectiveness , " the Medicines and Healthcare products Regulatory Agency ( MHRA ) chief executive June Raine said in a statement . 
She said that the MHRA " will seek advice from the Government ’s independent advisory body , the Commission on Human Medicines . 
The Commission will critically assess the data too before advising the UK government on the safety , quality and effectiveness of any potential vaccine . " 
" The safety of the public will always come first . 
Our job is to work to the highest standards and safety is our watchword . " 
It comes as Astra Zeneca/Oxford announced that another experimental coronavirus vaccine showed an average efficacy of 70 % in large scale trials and up to a 90 % efficacy in one dosing regimen . 
The UK government has ordered 100 million doses of the Astra Zeneca vaccine and 40 million doses of the Pfizer/Bio NTech vaccine . 
